Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection

F. Ansaldi, B. Bruzzone, G. Testino, M. Bassetti, R. Gasparini, P. Crovari, G. Icardi

Research output: Contribution to journalArticlepeer-review


Reduction of the window period of hepatitis C virus (HCV) infection represents an important goal in the transfusional and diagnostic setting. A prototype assay designed to simultaneously detect circulating HCV antigen and anti-HCV, has been developed. Aim of this study was to evaluate the performance of this new assay in terms of specificity and sensitivity and to compare its efficacy with commercial assays. To evaluate the specificity of the assay, 400 samples from the general population and 100 'difficult' sera, negative for anti-HCV, were tested. To assess sensitivity, the new test was used on 76 PCR-positive and anti-HCV negative sera, seven natural or commercial seroconversion panels that included 17 RNA-positive and anti-HCV negative sera and 31 anti-HCV positive sera, 20 weak anti-HCV positive sera, 80 viraemic and anti-HCV-positive sera from patients infected with different subtypes and 10 sera from patients with HBV-HCV or HIV-HCV co-infections. Of 500 anti-HCV negative samples, 499 (99.8%) were negative with a cut-off index

Original languageEnglish
Pages (from-to)5-10
Number of pages6
JournalJournal of Viral Hepatitis
Issue number1
Publication statusPublished - Jan 2006


  • Antigen
  • Diagnosis
  • HCV
  • Immunoassay
  • Window period

ASJC Scopus subject areas

  • Hepatology
  • Virology


Dive into the research topics of 'Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection'. Together they form a unique fingerprint.

Cite this